Mufin Green Finance reported a significant acceleration in profitability for the first quarter of FY27, with net profit surging more than threefold compared to the same period last year. The company posted a standalone net profit after tax of ₹1,401.12 lakh for the quarter ended June 30, 2026, compared to ₹410.99 lakh in the corresponding quarter of FY26. This represents a year-on-year growth of approximately 241%.

Revenue from operations also expanded robustly, rising 60% to ₹7,686.19 lakh from ₹4,801.71 lakh in Q1FY26. On a sequential basis, revenue grew 19% from ₹6,466.62 lakh in the fourth quarter of FY26. The company’s pre-tax profit before exceptional items was recorded at ₹1,881.55 lakh, up sharply from ₹550.48 lakh a year ago.

Financial Performance Overview

The financial results reflect strong top-line momentum translating into improved bottom-line figures. Earnings per share (EPS) on a basic and diluted basis stood at ₹0.71 per share, a substantial increase from ₹0.25 in the prior year period.

On a consolidated basis, the performance mirrored the standalone results. Consolidated revenue from operations was ₹7,686.19 lakh, while consolidated net profit after tax remained at ₹1,401.12 lakh. Consolidated EPS was also reported at ₹0.71. For context, consolidated revenue in Q1FY26 was ₹4,892.66 lakh, indicating consistent growth across both reporting structures.

What the Numbers Show

The divergence between the 60% revenue growth and the 241% profit expansion suggests notable operating leverage or improved cost efficiency during the quarter. Pre-tax profits grew at a faster clip than revenue, implying that operational expenses did not scale proportionately with income generation. Additionally, total comprehensive income for the period was reported at ₹1,097.51 lakh, which is lower than the net profit figure, indicating adjustments in other comprehensive income items that reduced the overall comprehensive gain despite strong core profitability.

Corporate Governance and Approval

The unaudited financial results for the quarter were reviewed by the Audit Committee and approved by the Board of Directors in a meeting held on August 11, 2026. The statutory auditors carried out a limited review of the financials as required under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Kapil Garg, Managing Director, signed off on the results. The full format of the quarterly financial results is available on the company’s website and the stock exchange platforms.

Mufin Green Finance reported a 345.6% year-on-year increase in net profit after tax (PAT) to ₹14.01 crore for the quarter ended June 30, 2026, signaling robust profitability momentum in its first quarter of FY27. The financial performance was anchored by a 64.3% rise in net interest income (NII) to ₹35.16 crore, supported by disciplined cost management that saw operating expenses decline 17.2% to ₹13.55 crore despite a 61.8% jump in interest income. This divergence between revenue growth and expense contraction highlights significant operating leverage achieved through the company’s digital-first, branch-light model.

The filing, submitted under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, discloses that profit before tax (PBT) surged 345.6% to ₹18.82 crore from ₹4.22 crore in Q1FY26. Pre-provisioning operating profit (PPOP) more than doubled to ₹62.98 crore, up 102.3% year-on-year. While provisions and write-offs increased 167.6% to ₹2.89 crore, they remained manageable relative to the top-line expansion, allowing bottom-line metrics to expand sharply. The company’s capital adequacy ratio (CRAR) stood at a robust 30.55%, providing a strong buffer against credit risks.

Portfolio Expansion and Asset Quality

Total assets under management (AUM) reached ₹1,599.23 crore as of June 2026, reflecting a 69.4% growth from ₹944 crore in Q1FY26. Disbursements in Q1FY27 totaled ₹449.40 crore, up 37.3% year-on-year. Gross non-performing assets (GNPA) remained stable at 1.91%, indicating that rapid scale-up has not compromised asset quality. The portfolio is diversified across four verticals, with Mediclaim Financing contributing 42% of AUM, followed by MSME & Corporate loans at 29%, Climate Financing at 26%, and Salary Saathi at 3%.

Mediclaim Financing emerged as the primary growth driver, with disbursements rising 56.2% to ₹247.08 crore and loan counts increasing 48.4% to 48,214. June 2026 alone saw a 74.6% year-on-year jump in loan counts, reflecting accelerating point-of-sale adoption. Meanwhile, the Salary Saathi vertical, secured through salary deduction-at-source MoUs with state governments, grew 38.4% quarter-on-quarter to ₹38.20 crore, driven largely by expansion into Assam.

Funding Strategy and Operational Efficiency

The company strengthened its funding base by onboarding Union Bank and Wint Wealth in June 2026, securing a ₹25.00 crore term loan and a ₹100.00 crore NCD facility. Total borrowings stood at ₹1,550.99 crore across 35+ lenders, with the cost of borrowings declining to 11.17% in Q1FY27 from 12.17% in Q4FY26. This reduction in funding costs directly contributed to margin expansion. The borrowing mix shifted towards Non-Convertible Debentures (NCDs), which now constitute 24% of total borrowings, up from 16% in March 2025.

Operational efficiency gains were evident in headcount optimization. Cumulative disbursements grew 6.9x to ₹2,217 crore since Q1FY26, while headcount fell 26.45% from 499 to 367 employees. This resulted in disbursement per employee rising to ₹6.04 crore, underscoring the scalability of its tech-led infrastructure. Credit ratings remain positive, with Acuité maintaining an A- (Stable) rating and CRISIL assigning an A+ (SO) rating to its securitized pools.

What the Numbers Show

The most striking analytical observation is the decoupling of revenue growth from operational costs. While interest income jumped 61.8%, operating expenses contracted 17.2%. This suggests that Mufin Green Finance is successfully leveraging fixed-cost digital platforms to absorb volume growth without proportional increases in staffing or overheads. Furthermore, the decline in cost of borrowings (from 12.17% to 11.17%) combined with stable GNPA levels indicates that the company is not merely growing volume but improving unit economics. The heavy reliance on Mediclaim financing (42% of AUM) presents a concentration risk, but the low Loss Given Default (LGD) of 1% ± 0.25% assigned by CRISIL mitigates this concern, validating the asset quality of this high-growth segment.